ClinConnect ClinConnect Logo
Search / Trial NCT02002299

Does Surface Tell us About the Invasive Front in Colorectal Cancer

Launched by ZEALAND UNIVERSITY HOSPITAL · Nov 29, 2013

Trial Information

Current as of September 01, 2025

Unknown status

Keywords

Colorectal Cancer Surface Invasive Front Tumor Budding

ClinConnect Summary

Timetable: From 1 August 2013 to 31 July 2014.

Organisational arrangements: The project is deleted from the pathology department, Roskilde Hospital, and surgical department, Roskilde Hospital.

inclusion criteria All colorectal surgical specimens having cancer were the patient did not receive neoadjuvant treatment received in the pathology department in accordance with current guidelines with the cutting of the tumor area in parallel slices and photographed, so there is macroscopic photo documentation.

Microscopic tumors classified as adenocarcinoma of glandular type, mucinous adenocarcin...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All surgical preparations from patients with colorectal cancer that did not receive neoadjuvant treatment received in the pathology department in accordance with current guidelines with the cutting of the tumor area in parallel slices and photographed, so there is macroscopic photo documentation.
  • Microscopic tumors classified as adenocarcinoma of glandular type, mucinous adenocarcinoma, signet ring cell carcinoma.
  • Exclusion Criteria:
  • All surgical preparations from patients with colorectal cancer where the patient received neoadjuvant therapy or when surgery preparation could not be received by current guidelines and all preparations where it is not possible to obtain macroscopic image of the parallel slices.
  • Microscopic tumors that can not be classified as adenocarcinoma of the glandular type, mucinous adenocarcinoma or signet ring cell carcinoma excluded.

About Zealand University Hospital

Zealand University Hospital is a leading academic medical center located in Denmark, dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital leverages its extensive expertise in various medical fields to improve patient outcomes and enhance treatment methodologies. With a commitment to rigorous scientific standards and ethical practices, Zealand University Hospital collaborates with multidisciplinary teams to explore new therapies and interventions, contributing significantly to the global body of medical knowledge. Through its state-of-the-art facilities and focus on patient-centered care, the hospital plays a pivotal role in shaping the future of medicine.

Locations

Roskilde, , Denmark

Patients applied

0 patients applied

Trial Officials

Susanne Eiholm, MD

Principal Investigator

Department of Pathology, Roskilde Hospital, Denmark

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials